With a follow-up time of 54 months, this study reported that local recurrence occurred in 2 patients (1.2%), enucleation was 3% (n = 5) and no patient developed metastatic disease. A large-treatment field (full aperture, involving > 10 clock hours) was identified as a risk factor for the development of secondary glaucoma and vision loss.